These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4483042)

  • 21. Should Mexico hold its horses?
    Kahler S
    J Am Vet Med Assoc; 1993 Oct; 203(8):1095-7. PubMed ID: 8244847
    [No Abstract]   [Full Text] [Related]  

  • 22. Venezuelan equine encephalitis.
    Johnson KM; Martin DH
    Adv Vet Sci Comp Med; 1974; 18(0):79-116. PubMed ID: 4609399
    [No Abstract]   [Full Text] [Related]  

  • 23. A field trial of a live-virus western encephalitis vaccine.
    Hughes JP; Johnson HN
    J Am Vet Med Assoc; 1967 Jan; 150(2):167-71. PubMed ID: 6067761
    [No Abstract]   [Full Text] [Related]  

  • 24. Venezuelan encephalitis.
    Lancet; 1973 Jan; 1(7793):29-30. PubMed ID: 4118544
    [No Abstract]   [Full Text] [Related]  

  • 25. Field studies of an attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83).
    Eddy GA; Martin DH; Reeves WC; Johnson KM
    Infect Immun; 1972 Feb; 5(2):160-3. PubMed ID: 4564397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveillance of Venezuelan equine encephalitis in the United States--1972.
    Moulthrop JI; Moore RM; Parker RL
    J Infect Dis; 1973 Oct; 128(4):572-3. PubMed ID: 4149690
    [No Abstract]   [Full Text] [Related]  

  • 27. CLINICAL AND IMMUNOLOGIC INTERRELATIONSHIP AMONG VENEZUELAN, EASTERN, AND WESTERN EQUINE ENCEPHALOMYELITIS VIRUSES IN BURROS.
    BYRNE RJ; FRENCH GR; YANCEY FS; GOCHENOUR WS; RUSSELL PK; RAMSBURG HH; BRAND OA; SCHEIDER FG; BUESCHER EL
    Am J Vet Res; 1964 Jan; 25():24-31. PubMed ID: 14103234
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
    Minke JM; Toulemonde CE; Coupier H; Guigal PM; Dinic S; Sindle T; Jessett D; Black L; Bublot M; Pardo MC; Audonnet JC
    Am J Vet Res; 2007 Feb; 68(2):213-9. PubMed ID: 17269889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pleasure horse practice.
    Mod Vet Pract; 1974 Jan; 55(1):19-23. PubMed ID: 4811090
    [No Abstract]   [Full Text] [Related]  

  • 30. Equine viral vaccines: the past, present and future.
    Minke JM; Audonnet JC; Fischer L
    Vet Res; 2004; 35(4):425-43. PubMed ID: 15236675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation in donkeys on an inactivated Venezuelan equine encephalitis vaccine.
    Villasmil DP; De Siger J; Barrientos MP; Mussgay M; Mackenzie RB
    Zentralbl Veterinarmed B; 1975 Mar; 22(2):162-8. PubMed ID: 1130149
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
    Heldens JG; Pouwels HG; van Loon AA
    Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular response to equine encephalomyelitis vaccine in skin window of horses.
    Zarrilli LW; Calhoun ML
    Am J Vet Res; 1970 Jan; 31(1):97-102. PubMed ID: 4905595
    [No Abstract]   [Full Text] [Related]  

  • 34. Post-vaccination reactions in donkeys vaccinated with African horse-sickness polyvalent vaccines.
    Ozawa Y; Hazrati A
    Bull Off Int Epizoot; 1967; 67(7):949-59. PubMed ID: 4303690
    [No Abstract]   [Full Text] [Related]  

  • 35. Guidelines for vaccination of horses. The American Association of Equine Practitioners' Vaccination Guidelines Subcommittee of the AVMA Council on Biologic and Therapeutic Agents.
    J Am Vet Med Assoc; 1995 Aug; 207(4):426-31. PubMed ID: 7591939
    [No Abstract]   [Full Text] [Related]  

  • 36. Public health aspects of Venezuelan equine encephalitis.
    Parker RL; Dean PB; Zehmer RB
    J Am Vet Med Assoc; 1973 May; 162(9):777-8. PubMed ID: 4735951
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
    Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Duration of immunity of horses vaccinated with strain TC-83 Venezuelan equine encephalomyelitis virus vaccine.
    Walton TE; Luedke AJ; Jochim MM; Crenshaw GL; Ferguson JA
    Proc Annu Meet U S Anim Health Assoc; 1973; (77):196-202. PubMed ID: 4534711
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus.
    Paillot R; Kydd JH; Sindle T; Hannant D; Edlund Toulemonde C; Audonnet JC; Minke JM; Daly JM
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):225-33. PubMed ID: 16621023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenicity of a Venezuelan equine encephalomyelitis serotype IE virus isolate for ponies.
    Sahu SP; Pedersen DD; Jenny AL; Schmitt BJ; Alstad AD
    Am J Trop Med Hyg; 2003 Apr; 68(4):485-94. PubMed ID: 12875302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.